HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Correction A correction has been published Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (85) Citing Articles via Google Scholar Google Scholar Articles by Raisz, L. G. Search for Related Content PubMed PubMed Citation Articles by Raisz, L. G. Related Collections Molecular Diagnostics and Genetics Arnold O. Beckman Conference Endocrinology and Metabolism

Physiology and Pathophysiology of Bone Remodeling

Lowell P. Weicker, Jr. General Clinical Research Center, University of Connecticut Health Center, MC-2806, 263 Farmington Ave., Farmington, CT 06030. Fax 960-679-1856; e-mail Raisz{at}nso.uchc.edu

The skeleton is a metabolically active organ that undergoes continuous remodeling throughout life. This remodeling is necessary both to maintain the structural integrity of the skeleton and to subserve its metabolic functions as a storehouse of calcium and phosphorus. These dual functions often come into conflict under conditions of changing mechanical forces or metabolic and nutritional stress.

The bone remodeling cycle involves a complex series of sequential steps that are highly regulated. The "activation" phase of remodeling is dependent on the effects of local and systemic factors on mesenchymal cells of the osteoblast lineage. These cells interact with hematopoietic precursors to form osteoclasts in the "resorption" phase. Subsequently, there is a "reversal" phase during which mononuclear cells are present on the bone surface. They may complete the resorption process and produce the signals that initiate formation. Finally, successive waves of mesenchymal cells differentiate into functional osteoblasts, which lay down matrix in the "formation" phase.

The effects of calcium-regulating hormones on this remodeling cycle subserve the metabolic functions of the skeleton. Other systemic hormones control overall skeletal growth. The responses to changes in mechanical force and repair of microfractures, as well as the maintenance of the remodeling cycle, are determined locally by cytokines, prostaglandins, and growth factors. Interactions between systemic and local factors are important in the pathogenesis of osteoporosis as well as the skeletal changes in hyperparathyroidism and hyperthyroidism. Local factors are implicated in the pathogenesis of the skeletal changes associated with immobilization, inflammation, and Paget disease of bone.© 1999 American Association for Clinical Chemistry

The following articles in journals at HighWire Press have cited this article:

				N. A. T. Hamdy Strontium ranelate improves bone microarchitecture in osteoporosis Rheumatology, October 1, 2009; 48(suppl_4): iv9 - iv13. [Abstract] [Full Text] [PDF]

				M. M. Dvorak, T.-H. Chen, B. Orwoll, C. Garvey, W. Chang, D. D. Bikle, and D. M. Shoback Constitutive Activity of the Osteoblast Ca2+-Sensing Receptor Promotes Loss of Cancellous Bone Endocrinology, July 1, 2007; 148(7): 3156 - 3163. [Abstract] [Full Text] [PDF]

				J. W. Triplett and F. M. Pavalko Disruption of {alpha}-actinin-integrin interactions at focal adhesions renders osteoblasts susceptible to apoptosis Am J Physiol Cell Physiol, November 1, 2006; 291(5): C909 - C921. [Abstract] [Full Text] [PDF]

				M. Shaarawy, S. Zaki, A.-M. Ramzi, M. E. Salem, and A. M. El-Minawi Feto-maternal Bone Remodeling in Normal Pregnancy and Preeclampsia Reproductive Sciences, July 1, 2005; 12(5): 343 - 348. [Abstract] [PDF]

				N. Pandit-Taskar, M. Batraki, and C. R. Divgi Radiopharmaceutical Therapy for Palliation of Bone Pain from Osseous Metastases J. Nucl. Med., August 1, 2004; 45(8): 1358 - 1365. [Abstract] [Full Text] [PDF]

				W Q Gan, S F P Man, A Senthilselvan, and D D Sin Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis Thorax, July 1, 2004; 59(7): 574 - 580. [Abstract] [Full Text] [PDF]

				S. Nakayamada, Y. Okada, K. Saito, M. Tamura, and Y. Tanaka {beta}1 Integrin/Focal Adhesion Kinase-mediated Signaling Induces Intercellular Adhesion Molecule 1 and Receptor Activator of Nuclear Factor {kappa}B Ligand on Osteoblasts and Osteoclast Maturation J. Biol. Chem., November 14, 2003; 278(46): 45368 - 45374. [Abstract] [Full Text] [PDF]

				S. B. Abramson and A. Amin Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage Rheumatology, September 1, 2002; 41(9): 972 - 980. [Abstract] [Full Text] [PDF]

				Y. Tanaka, S. Nakayamada, H. Fujimoto, Y. Okada, H. Umehara, T. Kataoka, and Y. Minami H-Ras/Mitogen-activated Protein Kinase Pathway Inhibits Integrin-mediated Adhesion and Induces Apoptosis in Osteoblasts J. Biol. Chem., June 7, 2002; 277(24): 21446 - 21452. [Abstract] [Full Text] [PDF]

				T. N. Kawahara, D. C. Krueger, J. A. Engelke, J. M. Harke, and N. C. Binkley Short-Term Vitamin A Supplementation Does Not Affect Bone Turnover in Men J. Nutr., June 1, 2002; 132(6): 1169 - 1172. [Abstract] [Full Text] [PDF]

				I. Kalajzic, J. Terzic, Z. Rumboldt, K. Mack, A. Naprta, F. Ledgard, G. Gronowicz, S. H. Clark, and D. W. Rowe Osteoblastic Response to the Defective Matrix in the Osteogenesis Imperfecta Murine (oim) Mouse Endocrinology, May 1, 2002; 143(5): 1594 - 1601. [Abstract] [Full Text] [PDF]